INDIOMIN MB (Burel Pharmaceuticals, Inc)
Welcome to the PulseAid listing for the INDIOMIN MB drug offered from Burel Pharmaceuticals, Inc. This Oxidation-Reduction Agent [EPC],Oxidation-Reduction Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Burel Pharmaceuticals, Inc |
| NON-PROPRIETARY NAME: | hyoscyamine sulfate, methenamine, methylene blue, and sodium phosphate, monobasic, monohydrate |
| SUBSTANCE NAME: | HYOSCYAMINE SULFATE; METHENAMINE; METHYLENE BLUE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Oxidation-Reduction Agent [EPC],Oxidation-Reduction Activity [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
| START MARKETING DATE: | 2015-09-28 |
| END MARKETING DATE: | 0000-00-00 |
INDIOMIN MB HUMAN PRESCRIPTION DRUG Details:
| Item Description | INDIOMIN MB from Burel Pharmaceuticals, Inc |
| LABELER NAME: | Burel Pharmaceuticals, Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | .12; 120; 10; 40.8(mg/1; mg/1; mg/1; mg/1) |
| START MARKETING DATE: | 2015-09-28 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 35573-315_3b411422-fe28-4de6-a811-8aa8b57317d9 |
| PRODUCT NDC: | 35573-315 |
| APPLICATION NUMBER: | |
Other HYOSCYAMINE SULFATE; METHENAMINE; METHYLENE BLUE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE Pharmaceutical Manufacturers / Labelers:
